<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37387323</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-3479</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</Title><ISOAbbreviation>Int J Gynaecol Obstet</ISOAbbreviation></Journal><ArticleTitle>Evaluation of long-COVID symptoms in women infected with SARS-CoV-2 during pregnancy.</ArticleTitle><Pagination><StartPage>148</StartPage><EndPage>156</EndPage><MedlinePgn>148-156</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ijgo.14972</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the symptoms of Long COVID (LC), frequency of symptoms, and possible risk factors in women diagnosed with coronavirus disease 2019 (COVID-19) during pregnancy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a single-center, cross-sectional, retrospective study in 99 pregnant women who were polymerase chain reaction-positive (PCR+) for COVID-19 between March 1, 2020 and April 30, 2022. The control group consisted of 99 women who gave birth between these dates and did not have COVID-19. We evaluated the clinical manifestations, symptom prevalence, and symptom characteristics of acute COVID-19 and the LC in the PCR+ group as well as questioned the control group for LC symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the women in the PCR+ group, 74 (74.7%) had at least one LC symptom, and the most common symptoms were fatigue (54; 72.9%), myalgia/arthralgia (49; 66.2%), and anosmia/ageusia (31; 41.9%). The rate of LC symptoms in the control group was 14 (14.1%). The prevalence of LC symptoms was higher in severely/critically symptomatic patients (23; 100%) in the acute period of disease than in asymptomatic/mildly symptomatic (51; 67.1%) (P&#x2009;=&#x2009;0.005). Hospitalization during acute infection (adjusted odds ratio [aOR]&#x2009;=&#x2009;13.30), having one or more symptoms (aOR&#x2009;=&#x2009;4.75), and having symptoms such as cough (aOR&#x2009;=&#x2009;6.27) and myalgia/arthralgia (aOR&#x2009;=&#x2009;12.93) increased the likelihood of LC.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Many women experienced LC after suffering acute COVID-19 in pregnancy, but LC prevalence was similar to the general population. LC correlates with severity, type, and number of symptoms of acute COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023 International Federation of Gynecology and Obstetrics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kandemir</LastName><ForeName>H&#xfc;lya</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8218-1893</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;lb&#xfc;l</LastName><ForeName>G&#xfc;l Alkan</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-6773-4573</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirti&#x15f;</LastName><ForeName>Emine</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6017-8228</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ney</LastName><ForeName>Selin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2065-5883</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanhal</LastName><ForeName>Cem Ya&#x15f;ar</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0003-0007-5769</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendilcio&#x11f;lu</LastName><ForeName>&#x130;brahim &#x130;nan&#xe7;</ForeName><Initials>&#x130;&#x130;</Initials><Identifier Source="ORCID">0000-0001-5611-5518</Identifier><AffiliationInfo><Affiliation>Division of Perinatology, The Department of Obstetrics and Gynecology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynaecol Obstet</MedlineTA><NlmUniqueID>0210174</NlmUniqueID><ISSNLinking>0020-7292</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018771" MajorTopicYN="N">Arthralgia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">puerperium</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37387323</ArticleId><ArticleId IdType="doi">10.1002/ijgo.14972</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470-473.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE); 2020. Accessed April 6, 2023. https://www.nice.org.uk/guidance/ng188</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance. 2021. Accessed 6 April 2023 https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html</Citation></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357.</Citation></Reference><Reference><Citation>Afshar Y, Gaw SL, Flaherman VJ, et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol. 2020;136(6):1117-1125.</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242.</Citation></Reference><Reference><Citation>Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020;2(2):100118.</Citation></Reference><Reference><Citation>Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.</Citation></Reference><Reference><Citation>Ames JL, Ferrara A, Avalos LA, et al. COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California. PLoS One. 2021;16(9):e0256891.</Citation></Reference><Reference><Citation>Smith ER, Oakley E, Grandner GW, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2023;228(2):161-177.</Citation></Reference><Reference><Citation>Alwan NA, Johnson L. Defining long COVID: going back to the start. Med (N Y). 2021;2(5):501-504.</Citation></Reference><Reference><Citation>Chen J, Cox S, Kuklina EV, Ferre C, Barfield W, Li R. Assessment of incidence and factors associated with severe maternal morbidity after delivery discharge among women in the US. JAMA Netw Open. 2021;4(2):e2036148.</Citation></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, et al. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2021;82(2):e1-e4.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.</Citation></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, et al. Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235-1241.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593-1607.</Citation></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830.</Citation></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. 2021;8:100186.</Citation></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607-1613.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605.</Citation></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396-398.</Citation></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5):e1089-e1098.</Citation></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, et al. Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC global follow-up protocol: StopCOVID cohort study. medRxiv. 2021:2021.02.17.21251895.</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-754.</Citation></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022.</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615.</Citation></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746.</Citation></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015-2016.</Citation></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in The Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73(11):e4058-e4063.</Citation></Reference><Reference><Citation>McCue C, Cowan R, Quasim T, Puxty K, McPeake J. Long term outcomes of critically ill COVID-19 pneumonia patients: early learning. Intensive Care Med. 2021;47(2):240-241.</Citation></Reference><Reference><Citation>Chudzik M, Babicki M, Kapusta J, et al. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID Registry of the PoLoCOV study. Viruses. 2022;14(8):1755.</Citation></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>